TAX1BP3 and cancer: In conclusion, we have demonstrated that TIP-1 is a suitable target for immunotherapy and imaging of cancer; the monoclonal antibody against TIP-1, 2C6F3, can be used to specifically image and treat tumors as a radio-immunoconjugate moiety.